Azurahisham Sah Pri1, J Geoffrey Chase2, Christopher G Pretty3, Geoffrey M Shaw4, Jean-Charles Preiser5, Jean-Louis Vincent6, Mauro Oddo7, Fabio S Taccone8, Sophie Penning9, Thomas Desaive10. 1. Centre for Bio-Engineering, Department of Mechanical Engineering, University of Canterbury, 20 Kirkwood Avenue, Christchurch, 8140, New Zealand. azurashisham.sahpri@pg.canterbury.ac.nz. 2. Centre for Bio-Engineering, Department of Mechanical Engineering, University of Canterbury, 20 Kirkwood Avenue, Christchurch, 8140, New Zealand. geoff.chase@canterbury.ac.nz. 3. Centre for Bio-Engineering, Department of Mechanical Engineering, University of Canterbury, 20 Kirkwood Avenue, Christchurch, 8140, New Zealand. chris.pretty@canterbury.ac.nz. 4. Department of Intensive Care, Christchurch Hospital, Riccarton Avenue, Christchurch, 8140, New Zealand. geoff.shaw@cdhb.govt.nz. 5. Department of Intensive Care, Erasme University Hospital (CUB), University of Brussels, Route de Lennik 808, 1070, Brussels, Belgium. jean-charles.preiser@erasme.ulb.ac.be. 6. Department of Intensive Care, Erasme University Hospital (CUB), University of Brussels, Route de Lennik 808, 1070, Brussels, Belgium. jlvincen@ulb.ac.be. 7. Department of Intensive Care, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland. Mauro.Oddo@chuv.ch. 8. Department of Intensive Care, Erasme University Hospital (CUB), University of Brussels, Route de Lennik 808, 1070, Brussels, Belgium. ftaccone@ulb.ac.be. 9. Cardiovascular Research Center, Universite de Liege, Allée du 6 Août 17, B4000, Liege, Belgium. Sophie.Penning@ulg.ac.be. 10. Cardiovascular Research Center, Universite de Liege, Allée du 6 Août 17, B4000, Liege, Belgium. tdesaive@ulg.ac.be.
Abstract
INTRODUCTION: Therapeutic hypothermia (TH) is often used to treat out-of-hospital cardiac arrest (OHCA) patients who also often simultaneously receive insulin for stress-induced hyperglycaemia. However, the impact of TH on systemic metabolism and insulin resistance in critical illness is unknown. This study analyses the impact of TH on metabolism, including the evolution of insulin sensitivity (SI) and its variability, in patients with coma after OHCA. METHODS: This study uses a clinically validated, model-based measure of SI. Insulin sensitivity was identified hourly using retrospective data from 200 post-cardiac arrest patients (8,522 hours) treated with TH, shortly after admission to the intensive care unit (ICU). Blood glucose and body temperature readings were taken every one to two hours. Data were divided into three periods: 1) cool (T <35°C); 2) an idle period of two hours as normothermia was re-established; and 3) warm (T >37°C). A maximum of 24 hours each for the cool and warm periods was considered. The impact of each condition on SI is analysed per cohort and per patient for both level and hour-to-hour variability, between periods and in six-hour blocks. RESULTS: Cohort and per-patient median SI levels increase consistently by 35% to 70% and 26% to 59% (P <0.001) respectively from cool to warm. Conversely, cohort and per-patient SI variability decreased by 11.1% to 33.6% (P <0.001) for the first 12 hours of treatment. However, SI variability increases between the 18th and 30th hours over the cool to warm transition, before continuing to decrease afterward. CONCLUSIONS: OCHA patients treated with TH have significantly lower and more variable SI during the cool period, compared to the later warm period. As treatment continues, SI level rises, and variability decreases consistently except for a large, significant increase during the cool to warm transition. These results demonstrate increased resistance to insulin during mild induced hypothermia. Our study might have important implications for glycaemic control during targeted temperature management.
INTRODUCTION: Therapeutic hypothermia (TH) is often used to treat out-of-hospital cardiac arrest (OHCA) patients who also often simultaneously receive insulin for stress-induced hyperglycaemia. However, the impact of TH on systemic metabolism and insulin resistance in critical illness is unknown. This study analyses the impact of TH on metabolism, including the evolution of insulin sensitivity (SI) and its variability, in patients with coma after OHCA. METHODS: This study uses a clinically validated, model-based measure of SI. Insulin sensitivity was identified hourly using retrospective data from 200 post-cardiac arrestpatients (8,522 hours) treated with TH, shortly after admission to the intensive care unit (ICU). Blood glucose and body temperature readings were taken every one to two hours. Data were divided into three periods: 1) cool (T <35°C); 2) an idle period of two hours as normothermia was re-established; and 3) warm (T >37°C). A maximum of 24 hours each for the cool and warm periods was considered. The impact of each condition on SI is analysed per cohort and per patient for both level and hour-to-hour variability, between periods and in six-hour blocks. RESULTS: Cohort and per-patient median SI levels increase consistently by 35% to 70% and 26% to 59% (P <0.001) respectively from cool to warm. Conversely, cohort and per-patient SI variability decreased by 11.1% to 33.6% (P <0.001) for the first 12 hours of treatment. However, SI variability increases between the 18th and 30th hours over the cool to warm transition, before continuing to decrease afterward. CONCLUSIONS: OCHA patients treated with TH have significantly lower and more variable SI during the cool period, compared to the later warm period. As treatment continues, SI level rises, and variability decreases consistently except for a large, significant increase during the cool to warm transition. These results demonstrate increased resistance to insulin during mild induced hypothermia. Our study might have important implications for glycaemic control during targeted temperature management.
Authors: Jessica Lin; Normy N Razak; Christopher G Pretty; Aaron Le Compte; Paul Docherty; Jacquelyn D Parente; Geoffrey M Shaw; Christopher E Hann; J Geoffrey Chase Journal: Comput Methods Programs Biomed Date: 2011-02-01 Impact factor: 5.428
Authors: Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek Journal: Circulation Date: 2008-10-23 Impact factor: 29.690
Authors: Christopher E Hann; J Geoffrey Chase; Jessica Lin; Thomas Lotz; Carmen V Doran; Geoffrey M Shaw Journal: Comput Methods Programs Biomed Date: 2005-03 Impact factor: 5.428
Authors: Christopher G Pretty; Aaron J Le Compte; J Geoffrey Chase; Geoffrey M Shaw; Jean-Charles Preiser; Sophie Penning; Thomas Desaive Journal: Ann Intensive Care Date: 2012-06-15 Impact factor: 6.925
Authors: Alicia Evans; Geoffrey M Shaw; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Leesa Pfeifer; Sophie Penning; Fatanah Suhaimi; Matthew Signal; Thomas Desaive; J Geoffrey Chase Journal: Ann Intensive Care Date: 2011-09-19 Impact factor: 6.925
Authors: Jae-Hyug Woo; Yong Su Lim; Hyuk Jun Yang; Sung Youl Hyun; Jin Seong Cho; Jin Joo Kim; Gun Lee Journal: Neurocrit Care Date: 2017-06 Impact factor: 3.210
Authors: Alexander D McHugh; J Geoffrey Chase; Jennifer L Knopp; Jennifer J Ormsbee; Diana G Kulawiec; Troy L Merry; Rinki Murphy; Peter R Shepherd; Hannah J Burden; Paul D Docherty Journal: J Diabetes Sci Technol Date: 2021-01-21
Authors: Young-Min Kim; Chun Song Youn; Soo Hyun Kim; Byung Kook Lee; In Soo Cho; Gyu Chong Cho; Kyung Woon Jeung; Sang Hoon Oh; Seung Pill Choi; Jong Hwan Shin; Kyoung-Chul Cha; Joo Suk Oh; Hyeon Woo Yim; Kyu Nam Park Journal: Crit Care Date: 2015-07-22 Impact factor: 9.097
Authors: Vincent Uyttendaele; Jennifer L Dickson; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase Journal: Crit Care Date: 2017-06-24 Impact factor: 9.097
Authors: J Geoffrey Chase; Jean-Charles Preiser; Jennifer L Dickson; Antoine Pironet; Yeong Shiong Chiew; Christopher G Pretty; Geoffrey M Shaw; Balazs Benyo; Knut Moeller; Soroush Safaei; Merryn Tawhai; Peter Hunter; Thomas Desaive Journal: Biomed Eng Online Date: 2018-02-20 Impact factor: 2.819